50 reports

The virology market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028. Viruses such as human immunodeficiency virus (HIV), flu virus, zika virus, Ebola virus, SARS-CoV-2, and poliovirus infect large population across the world.As the virus...

  • Infectious Disease
  • Antiviral
  • Infection Control
  • World
  • APAC
  • HIV AIDS Prevalence
  • Health Expenditure

Introduction to Antiviral Coatings Markets in 2022 The global Antiviral Coatings market is one of the high potential growth markets in the chemicals and materials industry, with a robust market size outlook and significant unmet opportunities for companies. The Antiviral Coatings market report is a comprehensive study...

  • Antiviral
  • World

Antiviral Coatings Market Review 2021 and Strategic Plan for 2022 - Insights, Trends, Competition, Growth Opportunities, Market Size, Market Share Data and Analysis Outlook to 2028 Antiviral Coatings Market Market Overview Antiviral Coatings Market market is expected to register an attractive growth...

  • Antiviral
  • World

As the global chemicals industry is at the onset of the recovery phase, companies are focusing on identifying and monetizing new opportunities in the industry. The majority of the chemical industries are likely to record volume growth of 4% to 8% in the short term, depending on the chemical sub-segment and product portfolio. A large volume...

  • Antiviral
  • World
  • Europe
  • Middle East
  • Africa
  • APAC

Major players in the antivirals market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd and AstraZeneca plc. The global antivirals market is expected to decline from $62.62 billion in 2020 to $52.13 billion...

  • Antiviral
  • World

Abstract: - Global Hepatitis C Treatment Market to Reach $82.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hepatitis C Treatment estimated at US$37.8 Billion in the year 2020, is projected to reach a revised size of US$82.3 Billion by 2027, growing at a CAGR of 11.7% over the analysis period...

  • Hepatitis Treatment
  • World
  • China
  • United States

Antiviral Combination Therapies Market – Scope of the Report This report on the global antiviral combination therapies market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030.The report provides the...

  • Antiviral
  • World

Respiratory Antiviral Treatment Market – Scope of the Report This report on the global respiratory antiviral treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030.The report provides...

  • Antiviral
  • World

Respiratory Antiviral Treatment Market – Scope of the Report This report on the global respiratory antiviral treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030.The report provides...

  • Antiviral
  • World

Major players in the anti-viral drug therapy market are AbbVie Inc., Bristol-Myers-Squibb, Cipla , F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi,...

  • Antiviral
  • World

A recent market report published on the sterile and antiviral packaging market provides global industry analysis for 2015-2019 & forecast for 2020-2030. The report offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical, as well as current growth parameters of the sterile...

  • Antiviral
  • World

Abstract: - Global Antivirals Drug Market to Reach $55.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antivirals Drug estimated at US$46.3 Billion in the year 2020, is projected to reach a revised size of US$55.4 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Nucleotide...

  • Antiviral
  • World
  • China
  • United States

Abstract: - Global Antimicrobial Ingredients Market to Reach 94.1 Thousand Tons by 2027 - Amid the COVID-19 crisis, the global market for Antimicrobial Ingredients estimated at 78.2 Thousand Tons in the year 2020, is projected to reach a revised size of 94.1 Thousand Tons by 2027, growing at a CAGR of 2.7% over the...

  • Antifungal
  • Antiviral
  • Antiseptics
  • Anti-Infective
  • World
  • China
  • United States

Global Antiviral Drugs Market 2021-2025 The analyst has been monitoring the antiviral drugs market and it is poised to grow by $ 19.89 bn during 2021-2025, progressing at a CAGR of over 4% during the forecast period. Our report on antiviral drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Antiviral
  • World

Forecasts by Drug Class (Reverse Transcriptase Inhibitors, Protease Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Others), by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antiviral Drugs...

  • Antiviral
  • World
  • APAC
  • Europe
  • Latin America

Anti-Viral Therapies Market by Type (Generic Drugs and Branded Drugs), Application (HIV, Hepatitis, Herpes Virus, Influenza, and Other Applications), and Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026 The...

  • Antiviral
  • World
  • APAC

Major players in the remdesivir market are Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy’s Laboratories. Gilead’s antiviral remdesivir is being tested in multiple phase 3 clinical trials as a treatment for moderately and severely ill...

  • Infectious Disease
  • Clinical Trial
  • Antiviral
  • Research And Development
  • United States
  • World

Global Infectious Enteritis Treatment Market 2022-2026 The analyst has been monitoring the infectious enteritis treatment market and it is poised to grow by $ 403.92 mn during 2022-2026, progressing at a CAGR of 5.09% during the forecast period. Our report on the infectious enteritis treatment market provides a holistic...

  • Pharmaceutical
  • Gastrointestinal Drug
  • Digestive System Disorder
  • Research And Development
  • Drug Development
  • Marketing Research
  • Antiviral
  • World
  • Drug Approval

Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Influenza), By Type (Branded, Generic), By Region, And Segment Forecasts, 2020 - 2027 The global antiviral drugs market size is expected to reach USD 46.9 billion by 2027. It is estimated to register a CAGR of...

  • Antiviral
  • HIV AIDS
  • World

The global herpes simplex virus treatment market reached a value of US$ 2.32 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 3.25 Billion by 2027 exhibiting a CAGR of 5.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...

  • Infectious Disease
  • Antiviral
  • World
  • Birth Rate

Single-Domain Antibody Platforms Market - Scope of Report A latest publication on the global single-domain antibody platforms market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global single-domain antibody platforms...

  • Antiviral
  • World

North America Liver Disease Treatment Market by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, and Chemotherapy) and Disease Type (Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, and Others): Opportunity Analysis and Industry...

  • Digestive System Disorder
  • Antiviral
  • North America

The global antiviral drug resistance market is expected to reach US$ 4,573.24 Mn in 2027 from US$ 2,572.26 Mn in 2018. The Antiviral drug resistance market is estimated to grow with a CAGR of 6.8% from 2019-2027. The market is driven by factors such as, rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS....

  • Antiviral
  • APAC
  • World
  • Europe
  • HIV AIDS Prevalence
  • HIV Incidence

The global hepatitis B virus (HBV) market is expected to reach US$35.63 billion in 2030, increasing at a CAGR of 29.41%, for the period of 2021-2030. The factors such as growth of pharmaceutical industry, increase in ageing population, upsurge in healthcare expenditure, urbanization leading to better monitoring and screening procedures and...

  • Hepatitis
  • Antiviral
  • World
  • Health Expenditure
  • Prescription Drug Sales

The global COVID-19 crisis has greatly increased industry demand for antimicrobial and antiviral coatings, especially for high touch surfaces in healthcare, retail, hotels, offices and the home. Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses, and are up to 1000 times more efficient...

  • Antiseptics
  • Antiviral
  • World

The global antiviral drugs market is expected to reach US$70.95 billion in 2024, increasing at a CAGR of 2.10%, for the duration of 2020-2024. The factors such as, increasing prevalence of HIV infections, upswing in international tourism, growth in geriatric population, increasing pharmaceutical R&D spending, rapid urbanization, upsurge in...

  • Antiviral
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic This analysis examines in detail how nanotechnology and nanomaterials can help in the fight against this pandemic disease, and ongoing mitigation strategies Nano-based products are currently...

  • Nanotechnology
  • Antiviral
  • Nanomaterial
  • Carbon Nanotube
  • Infectious Disease
  • Drug Delivery

Diagnostic testing, antiviral and antimicrobial coatings and surfaces, air-borne filtration, facemasks, PPE, drug delivery and therapeutics   Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic. This analysis...

  • Drug Delivery
  • Infectious Disease
  • Carbon Nanotube
  • Antiviral
  • United States

When the current global crisis has abated, efforts must turn to future preventative measures Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses and are up to 1000 times more efficient than previous technologies available on the market They can work on multiple levels at the same time:...

  • Antiviral
  • Antiseptics
  • Antifungal
  • World

“Capsid protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 9+ companies and 9+ pipeline drugs in Capsid protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Hepatitis
  • Antiviral
  • Ireland
  • World